Orphanet: Wyszukaj lek sierocy
x

Wyszukaj lek sierocy

*(*) pole obowiązkowe

Inne opcje wyszukiwania

5 Wyniki

MISSING CONTENT =

Wieloośrodkowe badania kliniczne

WŁOCHY

EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT

International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones - EsPhALL2017/COGAALL1631
Institution: Information not provided - IT

Więcej informacji
SZWAJCARIA

Suisse Alémanique
BASEL

A Randomized, Open Label, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Nilotinib Versus Imatinib in Adult Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST) (coordination)
Novartis International AG

Więcej informacji
SZWAJCARIA

Suisse Alémanique
BASEL

IMPRES: A 24-week Randomized Placebo-controlled, Double-blind Multi-centre Clinical Trial Evaluating the Efficacy and Safety of Oral QTI571 as an add-on Therapy in the Treatment of Severe Pulmonary Arterial Hypertension: Imatinib in Pulmonary Arterial Hypertension, a Randomized, Efficacy Study (PhaseIII) (coordination)
Novartis International AG

Więcej informacji
SZWAJCARIA

Suisse Alémanique
BASEL

An open-label, randomized phase II/III-study to compare the safety and efficacy of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+ acute lymphoblastic leukemia (Ph+ALL) (coordination)
Novartis Pharma Services AG

Więcej informacji
SZWAJCARIA

Suisse Alémanique
BASEL

An Open Label, Randomized Study of Nilotinib vs. Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Patients With Evidence of Persistent Leukemia by RQ-PCR (Phase III) (coordination)
Novartis Pharma Services AG

Więcej informacji